Abstract P3-09-09: Pre-operative pembrolizumab (pembro) with radiation therapy (RT) in patients with operable triple-negative breast cancer (TNBC)

Poster Session Abstracts Pub Date : 2020-02-14 DOI:10.1158/1538-7445.sabcs19-p3-09-09

H. McArthur, S. Shiao, S. Karlan, F. Amersi, B. Arnold, R. Basho, M. Burnison, A. Chung, C. Chung, C. Dang, A. Giuliano, Negin Habibi Khameneh, S. Knott, Cynthia Martin, P. McAndrew, M. Mita, D. Park, C. Abaya, A. Ho

引用次数: 4

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

摘要P3-09-09:术前派姆单抗(pembrolizumab, pembrolizumab)联合放疗(RT)治疗可手术三阴性乳腺癌(TNBC)患者

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Poster Session Abstracts

自引率

0.00%

发文量

期刊最新文献

Abstract PS6-01: How low is low risk: MINDACT updated outcome and treatment benefit in patients considered clinical low risk and stratified by genomic signature, age and nodal status Abstract PS14-01: Radium-223 in women with HR-positive bone-metastatic breast cancer receiving endocrine therapy: International phase 2, randomized, double-blind, placebo-controlled trial Abstract PS6-25: Cts5 tested in a Brazilian population: A tool that can predict global survival in early breast cancer ER+/HER2-, as well as the response to extended endocrine therapy Abstract PS1-32: A multicentre prospective feasibility study of carbon dye tattooing of biopsied axillary node and surgical localisation in breast cancer patients Abstract PS12-09: Pre-operative pembrolizumab (Pembro) with radiation therapy (RT) in patients with operable triple-negative breast cancer (TNBC)